DHR (Danaher Corp.) Forward P/E Multiple

DHR (Danaher Corporation) - company brandmark

The stability of Danaher Corp. (DHR) is based on asset diversification and the high demand for water purification equipment. The company's forward P/E history clearly confirms this trend, with the parameter reaching 25.00. Efficiency is driven by the DBS system and recurring revenue from consumables, which account for 70% of inflows. Full capacity utilization and the digital modernization of production lines guarantee the uninterrupted output of diagnostic systems.

Price to Future Earnings Ratio: Danaher (DHR) for 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for danaher.com (DHR)

- current price and projected stock value:
Fundamental valuation:Danaher Corporation DHR
Product sample of Danaher Corp.

The transformation of Danaher Corp. (DHR) into a biomedical tools platform makes earnings forecasts a key driver of valuation. The forward P/E is calculated as the ratio of the current share price to expected net income, reflecting investor market expectations. Analyzing the company's forward P/E chart, one can observe the current value of 25.00. This trend captures the effectiveness of the acquisition strategy and the implementation of lean manufacturing. A stable revenue stream ensures the resilience of the business's fundamental value.

Analysis of competing companies

Future Price to Earnings Intuitive Surgical Inc (ISRG)|BDX (Becton, Dickinson and Company) - Future Price to Earnings Multiple|Forward P/E Multiple STE (steris.com)|Market Cap to Projected Earnings westpharma.com (WST)|BAX - Future Price to Earnings|Market Cap to Projected Earnings Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Future Price to Earnings|TFX - Market Cap to Projected Earnings|Future Price to Earnings merit.com|Envista (NVST) - Market Cap to Projected Earnings|Projected Price to Earnings ICUI (ICU Medical, Inc.)|Market Cap to Future Earnings Ratio XRAY|Future Price to Earnings LeMaitre LMAT|Future Price to Earnings Multiple ATRC|STAA: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc (ZIMV) - Future Price to Earnings|Projected Price to Earnings AngioDynamics|CERS (cerus.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Teknova Inc TKNO|Future Price to Earnings Monogram Orthopedics (MGRM)|Sharps Tech - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (Utah Medical Products Inc.)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO